Effectiveness of the BBV-152 and AZD1222 vaccines among adult patients hospitalized in tertiary hospitals in Odisha with symptomatic respiratory diseases: A test-negative case–control study

Effectiveness of the BBV-152 and AZD1222 vaccines among adult patients hospitalized in tertiary hospitals in Odisha with symptomatic respiratory diseases: A test-negative case–control study

Two vaccines, namely BBV-152 (COVAXIN®) and AZD1222 (COVISHIELD™), were deployed against SARS-CoV-2 in India from January 16, 2021. Frontline health care workers were vaccinated first, followed by the adult population. However, limited data on vaccine effectiveness are available for the population o...

Full description

Bibliographic Details
Main Authors: Debdutta Bhattacharya, Srikanta Kanungo, Subrata Kumar Palo, Jaya Singh Kshatri, Matrujyoti Pattnaik, Shishirendu Ghosal, Pranab Mohapatra, C. Mohan Rao, Avinav Sahoo, Rudra Prasanna Mishra, Sanghamitra Mishra, Amiya Ranjan Mohanta, Chinki Doley, Sanghamitra Pati
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Public Health
Subjects:
BBV-152
AZD1222
COVAXIN
COVISHIELD
vaccine effectiveness
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1041586/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.1041586/full

Similar Items